<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <meta name="author" content="Akshay Gulabrao" />
  <title>CAPR Capricor Therapeutics</title>
  <style>
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    /* The extra [class] is a hack that increases specificity enough to
       override a similar rule in reveal.js */
    ul.task-list[class]{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      font-size: inherit;
      width: 0.8em;
      margin: 0 0.8em 0.2em -1.6em;
      vertical-align: middle;
    }
  </style>
  <link rel="stylesheet" href="style.css" />
</head>
<body>
<header id="title-block-header">
<h1 class="title">CAPR Capricor Therapeutics</h1>
<p class="author">Akshay Gulabrao</p>
<p class="date">2025 October 27</p>
</header>
<p>Capricor Therapeutics (CAPR) has a drug named Deramiocel (CAP-1002)
to treat Duchenne muscular dystrophy. Itâ€™s currently in Phase 3 and they
are due to release data in a few weeks.</p>
</body>
</html>
